Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mental disorders in patients with epilepsy.
Jeżowska-Jurczyk K, Kotas R, Jurczyk P, Nowakowska-Kotas M, Budrewicz S, Pokryszko-Dragan A. Jeżowska-Jurczyk K, et al. Among authors: budrewicz s. Psychiatr Pol. 2020 Feb 29;54(1):51-68. doi: 10.12740/PP/93886. Epub 2020 Feb 29. Psychiatr Pol. 2020. PMID: 32447356 Free article. Review. English, Polish.
[Pathophysiology and treatment of hiccup].
Budrewićz S, Góral M, Podemski R. Budrewićz S, et al. Przegl Lek. 2002;59(11):924-6. Przegl Lek. 2002. PMID: 12715724 Review. Polish.
Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
Białecka M, Kurzawski M, Roszmann A, Robowski P, Sitek EJ, Honczarenko K, Gorzkowska A, Budrewicz S, Mak M, Jarosz M, Gołąb-Janowska M, Koziorowska-Gawron E, Droździk M, Sławek J. Białecka M, et al. Among authors: budrewicz s. Pharmacogenet Genomics. 2012 Oct;22(10):716-24. doi: 10.1097/FPC.0b013e32835693f7. Pharmacogenet Genomics. 2012. PMID: 22890010
The impact of MRI white matter hyperintensities on dementia in Parkinson's disease in relation to the homocysteine level and other vascular risk factors.
Sławek J, Roszmann A, Robowski P, Dubaniewicz M, Sitek EJ, Honczarenko K, Gorzkowska A, Budrewicz S, Mak M, Gołąb-Janowska M, Koziorowska-Gawron E, Droździk M, Kurzawski M, Bandurski T, Białecka M. Sławek J, et al. Among authors: budrewicz s. Neurodegener Dis. 2013;12(1):1-12. doi: 10.1159/000338610. Epub 2012 Jul 20. Neurodegener Dis. 2013. PMID: 22831964
[Speech disorders in extrapyramidal diseases].
Budrewicz S, Słotwiński K, Podemski R. Budrewicz S, et al. Neurol Neurochir Pol. 2003;37 Suppl 5:47-54. Neurol Neurochir Pol. 2003. PMID: 15098331 Polish.
Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies - the Polish experience.
Czarnowska A, Brola W, Zajkowska O, Rusek S, Adamczyk-Sowa M, Kubicka-Bączyk K, Kalinowska-Łyszczarz A, Kania K, Słowik A, Wnuk M, Marona M, Podlecka-Piętowska A, Nojszewska M, Zakrzewska-Pniewska B, Jasińska E, Gołuch K, Lech B, Noga M, Perenc A, Popiel M, Lasek-Bal A, Puz P, Maciejowska K, Kucharska-Lipowska M, Lipowski M, Kapica-Topczewska K, Chorąży M, Tarasiuk J, Kochanowicz J, Kulikowska J, Wawrzyniak S, Niezgodzińska-Maciejek A, Pokryszko-Dragan A, Gruszka E, Budrewicz S, Białek M, Kurkowska-Jastrzębska I, Kurowska K, Stępień A, Włodek A, Ptasznik V, Pawełczyk M, Sobolewski P, Lejmel H, Strzalińska K, Maciejowski M, Tutaj A, Zwiernik J, Litwin A, Lewańczyk B, Paprocka I, Zwiernik B, Pawlos A, Borysowicz A, Narożnik A, Michałowska A, Nosek K, Fudala M, Milewska-Jędrzejczak M, Kułakowska A, Bartosik-Psujek H. Czarnowska A, et al. Among authors: budrewicz s. Neurol Neurochir Pol. 2021;55(2):212-222. doi: 10.5603/PJNNS.a2021.0031. Epub 2021 Apr 15. Neurol Neurochir Pol. 2021. PMID: 33856686
126 results